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ABSTRACT 
The closer contact with wildlife due to the growing human population and the destruction of natural habitats emphasizes the need of 
gaining insight into the role of animals as source of antimicrobial resistance. Here, we aim at characterizing the antimicrobial resistance 
genes and phylogenetic distribution of commensal E. coli from 62 wild mammals. Isolates exhibiting resistance to ≥1 antibiotic were 
detected in 25.8% of the animals and 6.4% carried an ESBL/AmpC-producing E. coli. Genetic mechanisms involved in third-generation 
cephalosporin resistance were: i) hyperproduction of chromosomal AmpC (hedgehog), ii) production of acquired CMY-2 β-lactamase 
(hedgehog), iii) production of SHV-12 and CTX-M-14 ESBLs (n=2, mink and roe-deer). ESBL genes were transferable by conjugation and 
blaCMY-2 was mobilized by a 95kb IncI1 plasmid. The distribution of the phylogenetic groups in the E. coli collection studied was B1 
(44.6%), B2 (24.6%), E (15.4%), A (4.6%) and F (3.1%). Five isolates (7.7%) were cryptic Escherichia clades (clade IV, 4 mice; clade V, 
1 mink). ESBL/AmpC-E. coli isolates showed different STs: ST1128/B1, ST4564/B1 (new), ST4996/B1 (new), and a non registered ST. 
This study contributes to better understand the E. coli population and antimicrobial resistance flow in wildlife and reports new AmpC-E. 
coli sequence types and a first described ESBL-producing Escherichia clade V isolate. 
 
INTRODUCTION 
Escherichia coli is an ubiquitous gram-negative bacillus that colonize the gastrointestinal (GI) tract of warm-blooded animals, including 
humans, and is widely distributed in the environment (water, soil and sediments) (Savagoau 1983). This species includes also pathogenic 
strains responsible for a variety of intestinal and extraintestinal diseases (neonatal meningitis, haemolytic uraemic syndrome, among 
others). It belongs to the Enterobacteriaceae family, whose members are becoming increasingly resistant to clinically critical antimicrobials 
such as fluoroquinolones and third/fourth generation cephalosporins, as shown in EARS-Net database 
(http://atlas.ecdc.europa.eu/public/index.aspx). Resistance to this last antimicrobial group is mainly mediated by the production of 
 
 
extended-spectrum beta-lactamases (ESBL) or AmpC beta-lactamases, which are enzymes able to efficiently hydrolyze the beta-lactam 
ring, inactivating the antibiotic. 
The extensive use, and misuse, of antibiotics in both human and veterinary medicine has led to the selection and global spread of resistant 
clones and gene-transfer elements (e.g. plasmids) carrying resistance determinants. These antimicrobial agents and antimicrobial resistant 
bacteria from hospital, farming and agricultural sources can be released from animal manure or wastewater and persist for a long time in 
the environment (Martínez 2009). The closer contact between wildlife and humans due to the growing human population and the 
destruction of natural habitats is increasing the opportunities for the transmission of antimicrobial resistance. Moreover, the high rates of 
antimicrobial resistant (AMR) bacteria detected in wild birds have led researchers to postulate them as sentinels, reservoirs and potential 
spreaders of antimicrobial resistance (Bonnedahl and Järhult 2014; Alcalá et al. 2016). Additionally, it is also important to remark that 
different natural conditions (e.g. heavy-metal rich habitats) and even antibiotic compounds produced by microbial communities can also 
exert a selective pressure favoring the emergence of resistance in the environment (Martínez 2009; Radhouani et al. 2014). Thus, there is a 
potential for wildlife to carry new or emerging genetic lineages associated with antimicrobial resistance. 
E. coli is recognized as a reliable indicator to trace the evolution of antimicrobial resistance and is one of the most used prokaryotic model 
organisms in molecular biology and genetics. To understand the flow of AMR E. coli through different ecosystems is essential to consider 
the population structure of E. coli. The growing genomic data led to re-define the E. coli phylogenetic structure in seven main phylogroups 
(A, B1, B2, C, D, E and F) and revealed the existence of five distinct cryptic lineages (clade I to V), which include strains phenotypically 
indistinguishable but genetically divergent from E. coli (Clermont et al. 2011; Clermont et al. 2013). These cryptic Escherichia clades have 
been recovered from environmental samples (Walk et al. 2009; Clermont et al. 2011; Luo et al. 2011; Berthe et al. 2013; Vignaroli et al. 
2014), birds and non-human mammals feces (Walk et al. 2009; Clermont et al. 2011) more frequently than from human GI tract, leading to 
the conclusion that they likely do not pose a risk to public health (Luo et al. 2011). However, data on cryptic Escherichia clades are still 
scarce. 
In this paper, we aim at identifying and characterizing the antimicrobial resistant mechanisms and phylogenetic distribution of commensal 
E. coli from wild mammals. Relevant isolates, such as those producing ESBL or acquired AmpC beta-lactamases and cryptic Escherichia 
clade strains, were deeper molecular analyzed. 
 
MATERIALS AND METHODS 
Sampling and bacterial identification 
Fecal samples from 62 different wild-mammals were collected between 2013-2015 in two different regions from northern Spain (Aragón 
and La Rioja). The animals included in this study belonged to the following species: 12 rodents (11 mice – Apodemus sylvaticus - and 1 rat 
– Rattus rattus -), 11 wild boars (Sus scrofa), 11 rabbits (Oryctolagus cuniculus), 8 deer (7 red deer - Cervus elaphus - and 1 roe deer – 
Capreolus capreolus -), 5 minks (Mustela lutreola), 4 hedgehogs (Erinaceus europaeus), 3 mouflons (Ovis musimon), 2 foxes (Vulpes 
vulpes), 2 martens (Martes martes), 2 badgers (Meles meles), 1 otter (Lutra lutra) and 1 genet (Genetta genetta). Fecal swabs, one per 
animal, were transported in Amies medium to the laboratory and conserved in refrigerated conditions until processing, within the first 48h. 
 
 
Samples were streaked on Levine agar plates and MacConkey agar supplemented with cefotaxime (2 µg/ml). After an overnight incubation 
at 37ºC, plates were examined for suspected E. coli colonies. Up to two colonies per plate were randomly selected and confirmed as E. coli 
by standard biochemical tests (Gram staining, indol, triple sugar iron) and the species-specific PCR for uidA gene detection (Heininger et 
al. 1999). 
Antimicrobial susceptibility testing 
Antimicrobial susceptibility was tested by the disc diffusion method in Mueller-Hinton agar plates for the following antimicrobials: 
ampicillin, amoxicillin/clavulanate, ceftazidime, cefotaxime, cefoxitin, imipenem, nalidixic acid, ciprofloxacin, gentamicin, amikacin, 
tobramycin, chloramphenicol, trimethoprim/sulfamethoxazole and tetracycline. Interpretation of the resulting inhibition zones was done 
according to the Clinical Laboratory Standards Institute document (CLSI 2015). E. coli ATCC 25922 was used as a control strain. 
Additionally, double-disc synergy test using ceftazidime, cefotaxime and amoxicillin/clavulanate was performed to screen for the 
production of ESBLs in all the recovered cefotaxime-resistant (CTXR) E. coli. When both isolates from a given plate showed the same 
phenotypic resistance pattern, only one isolate was selected and conserved at -80ºC for further molecular analyses. 
Characterization of antimicrobial resistance genes and integrons 
All the selected E. coli isolates were genetically characterized for the presence of specific resistance genes and mechanisms. PCR and 
subsequent sequencing was performed to identify the genes involved in β-lactam (blaCTX-M, blaSHV, blaTEM, blaOXA, blaPSE), quinolone 
[qnrA, qnrB, aac(6’)-Ib-cr, qepA], aminoglycoside [aac(3)-I, aac(3)-II, aac(3)-III, aac(3)-IV, strA, strB], tetracycline [tet(A), tet(B)], 
phenicol (cmlA, floR, catB3) and sulfonamide (sul1, sul2, sul3) resistances (Jouini et al. 2007; Alonso et al. 2017). The detection of 
acquired ampC genes was done by using a multiplex-PCR assay (Pérez-Pérez and Hanson 2002). Mutations in the chromosomal ampC 
promoter region were determined by PCR and sequencing. Additionally, in quinolone resistant isolates, amino acid substitutions in GyrA 
and ParC proteins were also screened by PCR and sequencing (Ruiz et al. 2012). 
The presence of class 1 and class 2 integrase encoding genes (intI1 and intI2, respectively), as well as the variable regions and 3’-conserved 
segments of the detected integrons were examined by PCR and sequencing (Sáenz et al. 2004; Alonso et al. 2017). 
Conjugal transfer and plasmid characterization 
Conjugation assays were carried out by filter mating to assess the transferability of ESBL and acquired AmpC encoding genes using the 
rifampicin-resistant E. coli C1520 (Lac-) and the sodium azide-resistant E. coli J53 as recipient strains. A donor:recipient ratio of 1:4 was 
used in this approach. Transconjugants were selected on MacConkey agar plates supplemented with cefotaxime (2 µg/mL) plus rifampicin 
(100 µg/mL) or sodium azide (100 µg/mL). They were subjected to antibiotic susceptibility tests and PCR analysis for the detection of bla 
genes and other resistance determinants, as described above. 
Plasmids were classified according to the diversity of replication proteins of major incompatibility (Inc) groups by PCR-based replicon 
typing (PBRT) using the genomic DNA of both original and transconjugant isolates (Carattoli et al. 2005). The number and size of 
plasmids in each transconjugant was analyzed by genomic DNA digestion with S1 nuclease followed by pulsed field gel electrophoresis 




Virulence genotyping of cryptic E. coli clades 
Isolates belonging to Escherichia clade IV and V were PCR screened for the presence of the following intestinal and extraintestinal 
virulence factors: eae  (encoding intim), stx1 (shiga toxins 1), stx2 (shiga toxins 2), bfp (bundle-forming pilus), fimA (encoding type 1 
fimbriae), hlyA (hemolysin), cnf1 (cytotoxic necrotizing factor), papG allele III (adhesion PapG class III), papC (P fimbriae), aer 
(aerobactin iron uptake system), usp (uropathogenic-specific protein), iutA (aerobactin receptor), ompT (outer membrane receptor), malX 
(pathogenicity island marker) and sat (secreted autotransporter toxin) (Vidal et al., 2005; Alonso et al. 2017). 
Molecular typing 
The diversity of the E. coli phylogroups in the collection was analyzed using the multiplex PCR-based assay (Clermont et al. 2013). 
Cryptic Escherichia clades were confirmed and assigned to lineages I, II, III, IV or V by a previously described method based on aes and 
chuA allele-specific amplifications (Clermont et al. 2011). 
Multilocus sequence typing (MLST) was carried out by amplifying and sequencing internal fragments of seven housekeeping genes (adk, 
fumC, gyrB, icd, mdh, purA, recA) for: i) All ESBL, acquired AmpC and hyperproducer chromosomal AmpC E. coli strains; and ii) Isolates 
belonging to the cryptic Escherichia clades. The resulting nucleotide sequences were analyzed and compared with those deposited in the 
Warwick MLST database (http://mlst.warwick.ac.uk/mlst/) to ascertain the corresponding sequence type (ST).  A neighbor-joining 
dendrogram was generated with MEGA7 software to obtain a phylogenetic reconstruction based on the concatenated sequences of the 
seven MLST loci from our ESBL/AmpC E. coli, cryptic Escherichia clade isolates and other reference strains belonging to the genus 
Escherichia (Walk et al. 2009; Luo et al. 2011; Vignaroli et al. 2015). 
RESULTS 
Antimicrobial profiles and detection of ESBL/acquired AmpC-producing E. coli 
E. coli isolates were recovered from all the 62 fecal samples analyzed. Although up to two isolates per plate were initially obtained, only in 
three samples >1 phenotypically distinct antimicrobial patterns were identified. Thus, a collection of 65 E. coli isolates were finally 
selected for further molecular analysis. Four of them grew in cefotaxime-supplemented MacConkey agar plates and, after the double-disk 
synergy test, two exhibited a positive ESBL phenotype. 
E. coli isolates exhibiting resistance to at least one antimicrobial agent were detected in fecal samples of 16 out of 62 animals (25.8 %) 
(Table 1). The highest resistance rates were observed for ampicillin, tetracycline, trimethoprim/sulfamethoxazole and nalidixic acid. Of 
particular interest was the detection of five multidrug-resistant isolates (≥3 different antimicrobial classes) and four CTXR E. coli strains. 
The genetic mechanism involved in the phenotypic resistance to third-generation cephalosporins exhibited by these isolates was: i) 
hyperproduction of chromosomal AmpC (n=1, hedgehog), ii) production of acquired AmpC β-lactamase (n=1, hedgehog) and, iii) 
production of ESBL (n=2, mink and roe deer). Interestingly, the ESBL-producing E. coli strain recovered from the roe deer was also 
resistant to tetracycline and nalidixic acid. 
Molecular characterization of antimicrobial resistance genes and integrons 
Molecular analysis showed the following acquired resistance determinants among the phenotypic resistant strains identified in this study 
[antimicrobial agent (number of resistant strains)/gene (number of strains)]: ampicillin (12)/blaTEM-1b (3), blaSHV-12 (1), blaCTX-M-14a (1), 
 
 
blaCMY-2 (1); tetracycline (6)/tet(A) (4), tet(B) (2); sulfonamides (5)/ sul2 (1), sul3 (1), sul1 + sul2 (3). Resistance to nalidixic acid was 
mediated by amino acid changes in chromosomally encoded GyrA (S83L) and ParC proteins (S80R). Isolates exhibiting resistance to both 
nalidixic acid and ciprofloxacin demonstrated to have an additional change in GyrA (S83L + D87N) and a substitution of a serine for an 
isoleucine at position 80 of the ParC protein. In some strains showing resistance to ampicillin or gentamicin, the genes responsible for these 
phenotypes could not be identified, which suggest the involvement of other resistance determinant or mechanism not evaluated in this 
study. Among the CTXR E. coli isolates (n=4; 6.1%), those identified as ESBL-producers harbored blaSHV-12 (roe deer) and blaCTXM14-a 
(mink) genes. Of the remaining two isolates, both recovered from hedgehogs and exhibiting an AmpC phenotype, one carried the acquired 
blaCMY-2 gene and the other presented mutations at positions -42, -18, -1 and +58 of the chromosomal ampC gene promoter. Class 1 
integrons containing the dfrA1-aadA1 gene cassette (GC) array were detected in 3 E. coli isolates (4.6%), and class 2 integrons carrying the 
classic dfrA1, sat2 and aadA1 GC were identified in two isolates (3.1%) (Table 1). 
Plasmid content and conjugal transfer of ESBL/acquired AmpC encoding genes 
In ESBL/acquired AmpC-producers, plasmid characterization demonstrated the presence of I1, F, FIB and P replicons, with sizes ranging 
from 20 to 95 kb (Table 2, Supplementary Figure 1). The ESBL/acquired AmpC genotype was transferable by conjugation in all the strains. 
The blaCMY-2 gene was likely mobilized by a 95 kb IncI1 plasmid from C7389 E. coli to the recipient strain (Supplementary Figure 1). In 
ESBL-producers (C8375, C7577), the plasmids carrying bla genes were transferred together with other plasmids (Supplementary Figure 1). 
Transconjugants of MDR C7577 E. coli isolate only acquired the ESBL phenotype/genotype, remaining susceptible to tetracycline and 
nalidixic acid. 
Molecular typing of ESBL, acquired AmpC and chromosomal hyperproducer AmpC E. coli isolates 
The distribution in our collection of commensal E. coli strains from wild mammals according to the major phylogenetic groups was as 
follows: B1 (n=29; 44.6%), B2 (n=16; 24.6%); E (n=10; 15.4%); A (n=3; 4.6%); F (n=2; 3.1%). Five isolates were classified as cryptic 
Escherichia clades (7.7%): four recovered from mice were identified as Escherichia clade IV (all assigned to the lineage ST322), and one 
obtained from a mink as Escherichia clade V. This last isolate harbored the blaCTX-M-14a gene and showed a novel point mutation at position 
184 (T → A) of the icd allele, leading to a new sequence type (not registered in the MLST database). Allelic combinations of clade IV and 
V isolates, together with those of some previously reported strains, are represented and compared in Table 3. 
The E. coli strain C7577, recovered from a roe deer and carrying the blaSHV-12 gene, was assigned to ST1128/B1 lineage. Molecular typing 
of the phenotypic AmpC isolates from hedgehogs revealed first described STs [ST/phylogroup (associated resistance mechanism)]: 
ST4564/B1 (production of CMY-2 enzyme) and ST4996/B1 (hyperproduction of chromosomal AmpC). 
Phylogenetic reconstruction of Escherichia lineages and virulence characterization of cryptic Escherichia clades 
Figure 1 shows the phylogenetic reconstruction of different Escherichia lineages (E. coli, cryptic Escherichia clade IV and V, E. 
fergusonii, and E. albertii) based on the concatenated nucleotide sequence of the 7 housekeeping loci used in MLST typing (3423 pb). 
Isolates typed in this study appear marked with a circle in the tree. In comparison with the E. coli included in the analysis, members of the 
cryptic clade IV and V, including those recovered in this study from one mink and mice’s feces, demonstrated to be divergent from the 
genetically viewpoint. Virulence genotyping of the cryptic Escherichia clades revealed the presence of the following genes: i) C6843, 






The present study, which examined the occurrence and molecular characteristics of AMR E. coli from wild mammals, showed a 
predominance of resistance against “old” antimicrobial agents (e.g. tetracycline, ampicillin, sulfonamides). This is also very common 
among human and livestock population (Guerra et al. 2003; Navajas-Benito et al. 2016), since these drugs have been in use for a long time 
both in clinical and veterinary practice. In fact, in agreement with previous studies, resistance profiles of wild mammal isolates seem to be 
the result of a “spill-over” from human medicine and livestock farming (Guenther et al. 2011).  Interestingly, four of the E. coli isolates 
recovered from two hegdehogs, a roe deer and a mink exhibited resistance to third generation cephalosporins and, in most of them (n=3), 
this phenotype was mediated by acquired AmpC or ESBL enzymes. These mechanisms, which confer resistance to newer antibiotics used 
in human medicine, are still relatively unusual in isolates from wildlife. However, in the last few years, ESBL/acquired AmpC-producing 
isolates have been increasingly reported (Costa et al. 2006; Literak et al. 2010; Radhouani et al. 2012; Alcalá et al. 2016; Alonso et al. 
2016). The prevalence in wild mammals vary significantly among regions and studies but can be considered as low to moderate (1.3 – 10 
%), which is in accordance to our results (6.4%), in comparison with the alarming high rates described in wild birds (Simões et al. 2010; 
Hasan et al. 2014; Alcalá et al. 2016). 
Focusing on these ESBL/acquired AmpC-producing isolates, different enzymes were detected in the present study. SHV-12 and CTX-M-
14 (in particular, CTX-M-14a, which is considered the predominant variant worldwide) were identified as responsible for the ESBL 
profiles exhibited by the E. coli isolates from roe deer and mink origin, respectively. Although many studies reported blaCTX-M-1 as the main 
ESBL gene found in wildlife (Bonnedahl et al. 2009; Dolejska et al. 2009; Literak et al. 2009; Poeta et al. 2009; Pinto et al. 2010; Simões 
et al. 2010; Alonso et al. 2016), blaCTX-M-14a and blaSHV-12 have also been frequently detected, especially among wild animals from the 
Iberian Peninsula (Costa et al. 2006; Alcalá et al. 2016; Cristóvão et al. 2017). This might simply reflect the higher occurrence of SHV-12 
and CTX-M-14 ESBL variants among clinical and livestock E. coli isolates from this geographical area. In fact, in Spain, even though 
CTX-M-15 is currently the predominant enzyme in human clinical specimens, SHV-12 and CTX-M-14 remain an important cause of 
community and healthcare-associated infections (Díaz et al. 2010; Merino et al. 2016). In the livestock production setting, these enzymes 
have been described as the most prevalent ESBLs identified in poultry and poultry meat (Egea et al. 2012; Ojer-Usoz et al. 2013). 
Moreover, both of the bla genes were shown to be transferable by conjugation, likely via IncI1 plasmids, which have been reported as the 
main group associated to the mobilization of blaSHV-12 (Alonso et al. 2017) and the second more frequently found among blaCTX-M-14-
carrying E. coli isolates in Spain, after IncK family (Valverde et al. 2009). However, additional experiments would be required to confirm 
this point. In E. coli strain C7389 isolated from a hedgehog, blaCMY-2 was identified as the gene responsible for the AmpC phenotype. This 
is the most commonly detected acquired AmpC β-lactamase in humans and animals worldwide (Jacoby, 2009).  In our study, both blaCMY-2 
and a 95kb plasmid of the IncI1 group were transferred from the donor to the recipient strain, suggesting the location of the AmpC gene in 
this conjugative plasmid. IncI1 group plasmids are frequently associated with the spread of blaCMY-2 (Hansen et al. 2016). 
It is also interesting to note that new sequence types of E. coli were demonstrated to be involved in the spread of ESBL/AmpC genotype in 
the environment (e.g. ST4564/B1; ST4996/B1, and a non registered ST showing a new icd allele), which underlines the undesirable 
consequences of their potential entry in the community or clinical setting. The ST1128/B1 clone, found in the blaSHV-12-carrying E. coli 
 
 
isolate from a roe deer, was previously reported in human gut microbiota (Touchon et al. 2009). However, the clonal genetic relatedness 
among isolates from different ecosystems cannot be well established by traditional typing methods and whole-genome sequencing 
approaches are recommended (de Been et al. 2014). Remarkably, to our knowledge, this study reported for the first time the detection of an 
Escherichia clade V member carrying an ESBL gene (blaCTX-M-14a). 
Cryptic Escherichia clades were discovered during a research focused on the genetic diversity and population structure of E. coli isolated 
from freshwater beaches (Walk et al. 2007). Subsequent MLST analysis involving a larger atypical E. coli collection demonstrated the 
existence of 5 novel clades (Clade I to V), which differed from recognized Escherichia species by hundreds of parsimoniously informative 
sites (Walk et al. 2009). Members of clade III, IV and V were considered environmentally adapted Escherichia lineages that appeared to be 
overrepresented in habitats outside the host (water, soil and aquatic sediments). However, there are also evidences supporting the relevant 
presence of Escherichia clades in birds (7.8-28.2%) and nonhuman mammals (3.2-8.2%), most likely because they may act as a spill-over 
host (Clermont et al. 2011; Walk et al. 2015). Our results are consistent with these observations and demonstrated a prevalence of 7.7% of 
Escherichia clade isolates in the intestine of wild mammals (clade IV, n=4; clade V, n=1). The phylogenetic reconstruction showed in 
Figure 1 allow to clearly distinguish them from E. coli isolates, especially members of clade V which are the most divergent. It is worth 
noting that, as shown Table 3, identical MLST allelic numbers were shared by more than one isolate belonging to a particular clade, which 
demonstrate a common genetic background regardless of their sources and geographical origins. Regarding virulence and antimicrobial 
resistance potential, the few existing studies on cryptic Escherichia clades suggest a lack of many determinants involved in intestinal and 
extraintestinal human infections and a low level of antimicrobial resistance (except for clade I) (Ingle et al. 2011). With regard to the first 
point, among the virulence factors evaluated in this study, only fimA gene was identified in Escherichia clade IV isolates from our 
collection. However, the strain belonging to clade V was found to carry more of these genes (fimA, malX, aer and ompT). In fact, this last 
virulence factor (ompT) was found to be very common among clade V members (77%), as well as aer gene that has also been detected 
quite frequently (32%) (Ingle et al. 2011). Interestingly, a recent study indicated that strains belonging to clade V exhibit a gene repertoire 
and adhesion properties similar to those of intestinal pathogenic strains (Vignaroli et al. 2015). This observation, together with the 
capability of clade V to carry resistance determinants against clinically important antibiotics (as shown by the detection of our blaCTX-M-14a-
producing strain), underline the need of further research on non-coli Escherichia isolates to elucidate their potential role in humans as 
opportunistic pathogens or source of new virulence/antibiotic resistance genes. 
Overall, the present study contributes to a better understanding of the E. coli population and antimicrobial resistance problematic in 
wildlife. It has been demonstrated that, although antimicrobial resistance levels among E. coli of wild mammals are not yet alarming, 
relevant mechanisms (ESBL, acquired AmpC) and genes encoding resistance against clinically critical antibiotics are also present in low 
selective pressure settings. Furthermore, new clones showing an AmpC phenotype and a non-coli Escherichia clade V isolate carrying 
blaCTX-M-14a ESBL gene have been reported for the first time. Further epidemiological studies and routine monitoring are needed to 
determine the role of wildlife as source of AMR bacteria or resistance genes in order to better control the global problem of antimicrobial 
resistance. 
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Fig. 1. Phylogenetic tree of Escherichia clade V, Escherichia clade IV, E. coli, E. fergusonii, E. albertii and S. enterica reconstructed from the concatenated sequences 
of the 7 MLST loci (3423 bp) using MEGA7. The evolutionary history was inferred using the Neighbor-Joining method. The evolutionary distances were computed 
using the Kimura 2-parameter method and are in the units of the number of base substitutions per site. The strains noted with a black circle correspond to those 





Table 1. Characteristics of the E. coli strains showing resistance against one or more antimicrobial agents in this study. 
Strain Species Phylogenetic 
group 
Resistance profilea Integrons ESBL/AmpC 
phenotype 
Mutations in QRDR Other resistance genes 
outside integrons 
Class 1 (VRb/3’CSc) Class 2 (VRb) GyrA ParC 
C6512 Erinaceus europaeus B1 AMP - -    - 
C6513 Erinaceus europaeus B1 AMP, AMC, NAL - - AmpC S83L S80R - 
C7388 Erinaceus europaeus A AMP, CHL, NAL, CIP, TET, SXT - -  S83L, D87N S80I sul2, tet(B), blaTEM-1b 
C7389 Erinaceus europaeus B1 AMP, AMC, CAZ, CTX, FOX - - AmpC   sul3, blaCMY-2 
C6842 Mus musculus A AMP - -    blaTEM-1b 
C6843 Mus musculus Clade IV GEN - -    - 
C6895 Mus musculus B1 GEN - -    - 
C6896 Rattus norvegicus E GEN, AMK - -    - 
C7373 Genetta genetta B1 - - dfrA1-sat2-aadA1    - 
C7374 Lutra lutra E AMP, TET, SXT dfrA1-aadA1/qacE∆1-sul1 -    sul2, tet(A) 
C8395 Neovison vison Clade V AMP, CTX - - ESBL   blaCTX-M-14a 
C7577 Capreolus capreolus B1 AMP, CAZ, CTX, NAL, TET - dfrA1-sat2-aadA1 ESBL S83L S80R tet(A), blaSHV-12 
C8415 Ovis musimon B1 AMP, TET, SXT dfrA1-aadA1/qacE∆1-sul1 -    sul2, tet(A) 
C8419 Ovis musimon B1 AMP, TET, SXT dfrA1-aadA1/qacE∆1-sul1 -    sul2, tet(A) 
C8401 Martes foina B1 AMP, NAL, CIP - -  S83L, D87N S80I blaTEM-1b 
C8399 Meles meles B1 AMP, TET - -    tet(B) 
a AMP: ampicillin; AMC: amoxicillin/clavulanate; CAZ: ceftazidime; CTX: cefotaxime; FOX: cefoxitin; CHL: chloramphenicol; NAX: nalidix acid; CIP: 
ciprofloxacin; GEN: gentamicin; AMK: amikacin; TET: tetracycline; SXT: trimethoprim/sulfamethoxazole. 
b VR: Variable region (gene cassettes included in the variable region). 
c 3’CS: 3’-Conserved Region. 
 
Table 2. Molecular typing, plasmid content and conjugative transfer of ESBL/AmpC-producing E. coli strains. 





Molecular typing  Plasmids  Conjugation and characterization of transconjugants 
ST Phylo 
group 










C8395 N. vison CTX-M-14a - NRa Clade V  3 125, 90, 65 I1, F, FIB  + 7 x 10
-3 AMP, CTX blaCTX-M-14 I1, F 90, 65 
C7577 C. capreolus SHV-12 - ST1128 B1  2 90, 20 I1, P  + 4.3 x 10
-3 AMP, CTX, CAZ blaSHV-12 I1, P 90, 20 
C7389 E. europaeus CMY-2 - ST4564 B1  1 95 I1  + 4.3 x 10
-2 AMP, AMC, CTX, CAZ, FOX blaCMY-2 I1 95 
C6513 E. europaeus - -42, -18, -1, +58 ST4996 B1  ND ND ND  ND ND ND ND ND ND a NR: non registered. 
 
Table 3. MLST data showing the allelic combinations of the cryptic Escherichia clade strains identified in this collection and others from previous studies. 
 
Strain Clade Origin adk fumC gyrB icd mdh purA recA ST Reference 
PR15E9 V Marine sediment 51 48 45 139 235 42 37 4105 Vignaroli et al. 2015 
PE9i15 V Marine sediment 51 468 220 266 235 42 37 3613 Vignaroli et al. 2015 
PE11E1 V Marine sediment 51 48 45 442 34 279 37 4104 Vignaroli et al. 2015 
E1118 V Water 51 48 45 287 34 42 37 2721 Luo et al. 2011 
C8395 V Mink 51 48 467 NRa 235 42 37 NR This study 
PE9i36 IV Marine sediment 356 531 387 441 56 322 63 4103 Vignaroli et al. 2015 
C6847 IV Mouse 82 87 73 79 56 60 63 322 This study 
C6950 IV Mouse 82 87 73 79 56 60 63 322 This study 
C6843 IV Mouse 82 87 73 79 56 60 63 322 This study 
C6846 IV Mouse 82 87 73 79 56 60 63 322 This study 
a NR: non registered. 
 
 
 
 
